Dry eye syndrome
Therapeutic area
Ophthalmology
Rare disease
No
- Definition
- A syndrome characterized by dryness of the cornea and conjunctiva. It is usually caused by a deficiency in tear production. Symptoms include a feeling of burning eyes and a possible foreign body presence in the eye.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Dry eye syndrome
- Therapeutic area
- Ophthalmology
- dry eye syndrome
- dry eye
- dry eye syndrome
- dry eye(s)
- eye(s), dry
- keratoconjunctivitis sicca
- sicca, keratoconjunctivitis
- All therapeutic areas
- Ophthalmology
- Severity
- Mild
- Inflammatory
- Syndromic
- MONDO ID
- MONDO:0006733
- Parent condition
- MONDO:0001854
Related records
Broader conditions (16)
- Conjunctival disorder
- Conjunctivitis
- Corneal disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Disorder of orbital region
- Disorder of visual system
- Eye adnexa disorder
- Eye disorder
- Human disease
- Inflammatory disease
- Keratitis
- Keratoconjunctivitis
- Lacrimal apparatus disorder
- Syndromic disease
Narrower conditions (1)
- Xerophthalmia
Trials (1,350)
- [KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001
- [KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome
- 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
- 2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD
- 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis
- 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis
- 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
- A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a Placebo
- A 2-week Clinical Comparison of SYSTANE® Ultra to Sensitive Eyes Rewetting Drops in Contact Lens Wearing Patients.
- A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
- A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
- A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
- A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
- A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
- A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
- A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
- A Clinical Trial to Assess Subjects With Dry Eye Disease.
- A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease
- A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
- A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)
Approved drugs (3)
- Lifitegrast
- Loteprednol etabonate
- Perfluorohexyloctane
Drugs in development (81)
- Acetylcysteine Phase 2
- Acoltremon Phase 1
- Amlisimod Phase 2
- Betamethasone Phase 2
- Betamethasone sodium phosphate Phase 2
- Brimonidine Phase 2
- Brimonidine tartrate Phase 3
- BRM-421 Phase 3
- Bromfenac Phase 3
- Canakinumab Phase 2
- Carbomer 910 Phase 2
- Carboxymethylcellulose sodium Phase 3
- Cenegermin Phase 3
- Cinhyaluronate sodium Phase 3
- Cis-urocanic acid Phase 1
- Cyclosporine Phase 3
- Dexamethasone Phase 2
- Dexamethasone phosphoric acid Phase 3
- Difluprednate Phase 2
- Diquafosol tetrasodium Phase 3
Other linked drugs (4)
- Diquafosol
- Phenylpropanolamine hydrochloride
- Sulfacetamide
- Tetracycline